Format

Send to

Choose Destination
J Hepatol. 2015 Oct;63(4):1052-3. doi: 10.1016/j.jhep.2015.06.024. Epub 2015 Jul 2.

Reply to: "Pivotal preclinical trial of the spheroid reservoir bioartificial liver".

Author information

1
Department of Surgery, Mayo Clinic, Rochester, MN, USA.
2
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
3
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA.
4
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA.
5
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
6
Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway.
7
Hepato-Neuro Laboratory, CRCHUM, Universite de Montreal, Quebec, Canada.
8
Brami Biomedical, Inc., Minneapolis, MN, USA.
9
Department of Surgery, Mayo Clinic, Rochester, MN, USA; William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA. Electronic address: nyberg.scott@mayo.edu.
PMID:
26143442
DOI:
10.1016/j.jhep.2015.06.024
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center